These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
266 related items for PubMed ID: 9514761
1. Membrane-induced alterations in HIV-1 Gag and matrix protein-protein interactions. Scarlata S, Ehrlich LS, Carter CA. J Mol Biol; 1998 Mar 27; 277(2):161-9. PubMed ID: 9514761 [Abstract] [Full Text] [Related]
2. Inhibition of viral assembly in murine cells by HIV-1 matrix. Hübner W, Chen BK. Virology; 2006 Aug 15; 352(1):27-38. PubMed ID: 16750235 [Abstract] [Full Text] [Related]
3. Role of myristylation in HIV-1 Gag assembly. Bouamr F, Scarlata S, Carter C. Biochemistry; 2003 Jun 03; 42(21):6408-17. PubMed ID: 12767222 [Abstract] [Full Text] [Related]
4. Molecular modelling study of HIV p17gag (MA) protein shell utilising data from electron microscopy and X-ray crystallography. Forster MJ, Mulloy B, Nermut MV. J Mol Biol; 2000 May 19; 298(5):841-57. PubMed ID: 10801353 [Abstract] [Full Text] [Related]
16. Influence of MA internal sequences, but not of the myristylated N-terminus sequence, on the budding site of HIV-1 Gag protein. Gallina A, Mantoan G, Rindi G, Milanesi G. Biochem Biophys Res Commun; 1994 Nov 15; 204(3):1031-8. PubMed ID: 7980574 [Abstract] [Full Text] [Related]
17. The N-terminal matrix domain of HIV-1 Gag is sufficient but not necessary for viral protein U-mediated enhancement of particle release through a membrane-targeting mechanism. Deora A, Spearman P, Ratner L. Virology; 2000 Apr 10; 269(2):305-12. PubMed ID: 10753709 [Abstract] [Full Text] [Related]
18. Human immunodeficiency virus type 1 KK26-27 matrix mutants display impaired infectivity, circularization and integration but not nuclear import. Mannioui A, Nelson E, Schiffer C, Felix N, Le Rouzic E, Benichou S, Gluckman JC, Canque B. Virology; 2005 Aug 15; 339(1):21-30. PubMed ID: 15963546 [Abstract] [Full Text] [Related]
19. Defect of human immunodeficiency virus type 2 Gag assembly in Saccharomyces cerevisiae. Morikawa Y, Goto T, Yasuoka D, Momose F, Matano T. J Virol; 2007 Sep 15; 81(18):9911-21. PubMed ID: 17609278 [Abstract] [Full Text] [Related]
20. Construction and characterization of a fluorescently labeled infectious human immunodeficiency virus type 1 derivative. Müller B, Daecke J, Fackler OT, Dittmar MT, Zentgraf H, Kräusslich HG. J Virol; 2004 Oct 15; 78(19):10803-13. PubMed ID: 15367647 [Abstract] [Full Text] [Related] Page: [Next] [New Search]